glp 1 pen tirzepatida GLP-1s appear to cut cancer risk. Researchers are asking why and how : NPR glp 1 pen tirzepatida Q&A:

Witkiewitz, K

The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort

These mechanisms are closely linked to pathological changes, including ion channel dysregulation, aging, hypoxic-stress injury, fibrosis, and autonomic nervous dysfunction (Schmig et al., 1995

We were impressed with the consistent formulation quality and the GMP-certified, NSF Certified for Sport manufacturing, which gives confidence in dose accuracy

Some are obvious: action hero Jason Statham in a shoot 'em up game

Kawahara M, Kato-Negishi M, Tanaka K